| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/30/2009 | US20090192087 Methods and Compositions Using Klotho-FGF Fusion Polypeptides |
| 07/30/2009 | US20090192086 Identification of a novel bhd gene |
| 07/30/2009 | US20090192085 FKBP-L And Uses Thereof |
| 07/30/2009 | US20090192082 Cxcr4 antagonist treatment of hematopoietic cells |
| 07/30/2009 | US20090192081 Casein derived peptides and uses thereof |
| 07/30/2009 | US20090192073 Method for producing insulin analogs having a dibasic b chain terminus |
| 07/30/2009 | US20090192072 Insulin and IGF-1 Receptor Agonists and Antagonists |
| 07/30/2009 | US20090191650 Diagnosing alzheimer's disease via presence of variant brain membrane protein |
| 07/30/2009 | US20090191629 Mammalian chemokine reagents |
| 07/30/2009 | US20090191624 Use of transthyretin peptide/protein fussions to increase the serum half-life of pharmacologically active peptides/proteins |
| 07/30/2009 | US20090191622 Synthetic nucleic acids from aquatic species |
| 07/30/2009 | US20090191606 Organic compounds |
| 07/30/2009 | US20090191591 Taurine Transporter Gene |
| 07/30/2009 | US20090191579 Analgesia with minimal tolerance and dependence by a mu opioid receptor agonist that also binds filamin a |
| 07/30/2009 | US20090191578 Canis sphingosine 1-phosphate receptor isoform 5 |
| 07/30/2009 | US20090191575 Tumor marker and method for determination of the occurrence of cancerous disease |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191570 Inhibition of Interaction of PSD93 and PSD95 with nNOS and NMDA Receptors |
| 07/30/2009 | US20090191569 Mammalian Cytokines; Related Reagents |
| 07/30/2009 | US20090191555 HCV NS3-NS4 Protease Resistance Mutants |
| 07/30/2009 | US20090191550 Diagnosis of whipple's disease |
| 07/30/2009 | US20090191268 Allergy vaccines |
| 07/30/2009 | US20090191255 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 07/30/2009 | US20090191241 Method and compositions for immunization with the pseudomonas v antigen |
| 07/30/2009 | US20090191240 Flavivirus Vaccines |
| 07/30/2009 | US20090191239 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/30/2009 | US20090191237 Methods and reagents for vaccination which generate A CD8 T cell immune response |
| 07/30/2009 | US20090191236 comprises claimed amino acid sequence or an immunogenic fragment thereof wherein the protein elicits production of antibodies that interfere with invasion by Babesia bovis into erythrocytes |
| 07/30/2009 | US20090191235 Conformationally stabilized hiv envelope immunogens and triggering hiv-1 envelope to reveal cryptic v3-loop epitopes |
| 07/30/2009 | US20090191234 Vaccine |
| 07/30/2009 | US20090191233 Influenza antigen delivery vectors and constructs |
| 07/30/2009 | US20090191231 Prevention and treatment of amyloidogenic disease |
| 07/30/2009 | US20090191229 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 07/30/2009 | US20090191222 Metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression |
| 07/30/2009 | US20090191216 Antibody or a fragment thereof, having neutralizing activity against HIV |
| 07/30/2009 | US20090191210 Method for inhibiting tumor invasion or spreading in a subject |
| 07/30/2009 | US20090191192 Humanized anti-ccr2 antibodies and methods of use therefor |
| 07/30/2009 | US20090191189 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 07/30/2009 | US20090191184 DcR3 polypeptide, A TNFR homolog |
| 07/30/2009 | US20090191166 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 07/30/2009 | US20090191150 Methods of treating infections using il-21 |
| 07/30/2009 | US20090191148 Cytokine muteins |
| 07/30/2009 | US20090191146 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/30/2009 | US20090191124 PDGF-RBeta BINDERS |
| 07/30/2009 | CA2713189A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
| 07/30/2009 | CA2713126A1 Lytic domain fusion constructs and methods of making and using same |
| 07/30/2009 | CA2713120A1 Transcriptional activators involved in abiotic stress tolerance |
| 07/30/2009 | CA2713055A1 Selective exosite inhibition of papp-a activity against igfbp-4 |
| 07/30/2009 | CA2712757A1 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| 07/30/2009 | CA2712567A1 Plants having enhanced yield-related traits and a method for making the same |
| 07/30/2009 | CA2712182A1 Proteinaceous binding molecules comprising purification tags or inert variable domains |
| 07/29/2009 | EP2083081A1 Compositions and methods of treating disease with FGFR fusion proteins |
| 07/29/2009 | EP2083080A1 Process for the preparation of l-amino acids using strains of the Enterobacteriaceae family which contain an enhanced rseA or rseC gene |
| 07/29/2009 | EP2083079A1 Apo-2DcR |
| 07/29/2009 | EP2083072A1 Stem-regulated, plant defense promotor and uses thereof in tissue-specific expression in monocots |
| 07/29/2009 | EP2083018A2 Compositions and methods relating to STOP-1 |
| 07/29/2009 | EP2083016A1 Bacterial superantigen vaccines |
| 07/29/2009 | EP2083015A2 Biosensor compositions and methods of use |
| 07/29/2009 | EP2082749A2 Prevention and treatment of Alzheimer's disease |
| 07/29/2009 | EP2082051A1 Methods and means for removal of a selected dna sequence |
| 07/29/2009 | EP2082042A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/29/2009 | EP2082040A2 Use of transcription factor inhibitor in the manufacture of a medicament |
| 07/29/2009 | EP2082029A2 Metabolically engineered escherichia coli for enchanced production of sialic acid |
| 07/29/2009 | EP2081959A2 Polypeptide monomers and dimers containing mutated ilt |
| 07/29/2009 | EP2081958A1 Peptide extended insulins |
| 07/29/2009 | EP2081957A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 07/29/2009 | EP2081956A2 Method of cell culture and method of treatment comprising a vepo protein variant |
| 07/29/2009 | EP2081955A1 Metastin derivatives and use thereof |
| 07/29/2009 | EP2081953A2 Immunogenic pcpa polypeptides and uses thereof |
| 07/29/2009 | EP2081551A1 Dried reconstituted vesicle formation for pharmaceutical application |
| 07/29/2009 | EP2081442A2 Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media |
| 07/29/2009 | EP2081429A1 Methods relating to peripheral administration of nogo receptor polypeptides |
| 07/29/2009 | EP1828240B1 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 07/29/2009 | EP1741791A9 Method and kit for the genotypification of hla-b27 based on real time pcr |
| 07/29/2009 | EP1670511B1 Cripto antagonism of activin and tgf-b signaling |
| 07/29/2009 | EP1572897B1 Ordered biological nanostructures formed from chaperonin polypeptides |
| 07/29/2009 | EP1549679B1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 07/29/2009 | EP1491890B1 Method of evaluating hair growth-promoting activity |
| 07/29/2009 | EP1401473B1 Transporters comprising spaced arginine moieties |
| 07/29/2009 | EP1293567B1 Ligand to gpr8 and dna thereof |
| 07/29/2009 | EP1292676B1 Mutation associated with epilepsy |
| 07/29/2009 | EP1287125B1 Dna sequences encoding dystrophin minigenes and methods of use thereof |
| 07/29/2009 | EP1283868B1 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 07/29/2009 | EP1086223B1 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/29/2009 | EP1025253B2 Positive-negative selection for homologous recombination |
| 07/29/2009 | EP1002110B2 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 07/29/2009 | EP0980434B1 Intracellular production of hepatitis c e2 truncated polypeptid |
| 07/29/2009 | EP0879284B1 Gene expression vectors which generate an antigen specific immune response and methods of using the same |
| 07/29/2009 | CN101495508A Model taste cells and methods of use for identifying modulators of taste sensation |
| 07/29/2009 | CN101495507A Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 07/29/2009 | CN101495506A Compositions and methods for the delivery of oxygen |
| 07/29/2009 | CN101495505A Chiral compounds substituted with phosphonate ester or phosphonic acid |
| 07/29/2009 | CN101495504A Materials and methods for the generation of fully 2'-modified nucleic acid transcripts |
| 07/29/2009 | CN101495503A Tyrosine kinase inhibitor compositions and methods for manufacturing and using them in the treatment of disease |
| 07/29/2009 | CN101492502A Nanog inhibitory type mutant and uses in Nanog function research |
| 07/29/2009 | CN101492501A Penaeus japonicus Rab protein, coded sequence and uses thereof |
| 07/29/2009 | CN101492500A Soybean 11S globulin separation extraction method |
| 07/29/2009 | CN101492499A Rice fibril controlling gene OsRHL1 and uses thereof |
| 07/29/2009 | CN101492498A Plant stress-resistant associated protein, encoding gene TaERECTA and uses |
| 07/29/2009 | CN101492497A Expression purification process for tubercle bacillus differential recombinant protein and uses thereof |